We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Phase III study of capecitabine plus oxaliplatin compared with continuous-infusion fluorouracil plus oxaliplatin as first-line therapy in metastatic colorectal cancer: final report of the Spanish Cooperative Group for the Treatment of Digestive Tumors Trial.
- Authors
Díaz-Rubio, Eduardo; Tabernero, Jose; Gómez-España, Auxiliadora; Massutí, Bartomeu; Sastre, Javier; Chaves, Manuel; Abad, Alberto; Carrato, Alfredo; Queralt, Bernardo; Reina, Juan José; Maurel, Joan; González-Flores, Encarnación; Aparicio, Jorge; Rivera, Fernando; Losa, Ferrán; Aranda, Enrique; Spanish Cooperative Group for the Treatment of Digestive Tumors Trial
- Abstract
The aim of this phase III trial was to compare the efficacy and safety of capecitabine plus oxaliplatin (XELOX) versus Spanish-based continuous-infusion high-dose fluorouracil (FU) plus oxaliplatin (FUOX) regimens as first-line therapy for metastatic colorectal cancer (MCRC).
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2007, Vol 25, Issue 27, p4224
- ISSN
1527-7755
- Publication type
Journal Article
- DOI
10.1200/JCO.2006.09.8467